PDL BioPharma, Inc. Derivative Asset, Current
PDL BioPharma, Inc. had Derivative Asset, Current of $0 as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Derivative Instruments and Hedges, Assets
us-gaap:DerivativeAssetsCurrent · last filed 2017-03-01
- 2016-12-31: Derivative Asset, Current $0.00.
- 2016-03-31: Derivative Asset, Current $0.00.
- 2015-12-31: Derivative Asset, Current $2.80M.
- 2015-09-30: Derivative Asset, Current $4.60M.
| Period end | Derivative Asset, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.80M 10-K · filed 2017-03-01 |
| 2015-09-30 | $4.60M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $6.99M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $11.67M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $3.35M 10-K · filed 2016-02-23 |
| 2014-09-30 | $252.00K 10-Q · filed 2014-11-10 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 |
| 2013-03-31 | $1.18M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $0.00 10-Q · filed 2013-05-09 |
| 2011-12-31 | $1.84M 10-K · filed 2013-03-01 |